---
title: "Allogene Therapeutics, Inc. (ALLO.US) — 公司概况"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ALLO.US/overview.md"
symbol: "ALLO.US"
name: "Allogene Therapeutics, Inc."
parent: "https://longbridge.com/zh-CN/quote/ALLO.US.md"
datetime: "2026-04-15T09:32:11.882Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLO.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLO.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLO.US/overview.md)
---

# Allogene Therapeutics, Inc. (ALLO.US) — 公司概况

## 基本信息

| 项目 | 详情 |
|------|--------|
| 行业 | 生物技术 |
| 交易所 | US Market |
| 地址 | 210 East Grand Avenue, South San Francisco, California, United States |
| 官网 | [allogene.com](https://allogene.com) |

## 公司简介

Allogene Therapeutics, Inc.是一家临床阶段的免疫肿瘤学公司，开发和商业化基因工程异体 T 细胞疗法，用于治疗癌症和自身免疫疾病。该公司开发了一系列多种异体 CAR T 细胞产品候选药物，利用蛋白质工程、基因编辑、基因插入和先进的专有 T 细胞制造技术。该公司还在开发 cemacabtagene ansegedleucel（cema-cel），这是一种针对 CD19 的工程异体 CAR T 细胞产品候选药物，用于治疗大 B 细胞淋巴瘤（LBCL）

## 核心管理层

| 名称 | 职位 |
|------|-------|
| Arie S. Belldegrun | Co-Founder & Executive Chairman |
| David D. Chang | Co-Founder, President, CEO & Director |
| Joshua A. Kazam | Co-Founder & Director |
| Zachary J. Roberts | Executive VP of Research & Development and Chief Medical Officer |
| Geoffrey M. Parker | Executive VP & CFO |
| Franz Bernhard Humer | Lead Independent Director |
| Owen N. Witte | Independent Director |

## 主要股东

| 名称 | 占比 | 报告日期 |
|------|-------|-------------|
| Pfizer Venture Investments LLC | 9.04% | 2025-12-31 |
| TPG Capital, L.P. | 7.68% | 2025-12-31 |
| BlackRock, Inc. | 7.25% | 2025-12-31 |
| Citadel Advisors LLC | 4.97% | 2025-12-31 |
| The Vanguard Group, Inc. | 3.80% | 2025-12-31 |
| PRIMECAP Management Company | 3.34% | 2025-12-31 |
| David D. Chang | 2.44% | 2026-03-16 |
| Arie S. Belldegrun | 2.40% | 2026-02-02 |
| Patient Square Capital, LP | 2.04% | 2025-12-31 |
| Geode Capital Management, LLC | 1.61% | 2025-12-31 |

## 业务构成

| 业务线 | 营收 | 占比 |
|---------|---------|-------|
| 药品 | 22000 | 100% |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "Allogene Therapeutics, Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "药品",
        "ratio": 100
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```

## 地区分布

| 地区 | 营收 | 占比 |
|--------|---------|-------|
| 美国 | 22000 | 100% |


---

> **免责声明: 本文仅供参考，不构成任何投资建议。**